Ledger.Open graph →
SEC Form D · filed October 15, 2019

Elicio Therapeutics, Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Robert Ruffolo · Cambridge, MADirectorDaniel Geffken · Cambridge, MAExec · DirectorRobert Connelly · Cambridge, MAExec · DirectorJulian Adams · Cambridge, MAExec · DirectorIsaac Kohlberg · Cambridge, MADirectorFrank Haluska · CAMBRIDGE, MADirectorWcp Holdings LLC · Reston, VADirectorJoseph Woo · PALO ALTO, CAExec · DirectorMark Alviano · Cary, NCExec · DirectorHenry Ellenbogen · Chevy Chase, MDExec · DirectorKevin W. Schuyler · Charlottesville, VADirectorCarol Lizak · San Francisco, CAExec · DirectorSteven King · San Francisco, CADirectorJonathan Wolin · San Francisco, CAExec · DirectorJames Bochnowski · San Francisco, CAExec · DirectorJohn Micek, Iii · San Francisco, CADirectorFrank Haluska · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗